Investigate the epidemiology, risk factors and impact on clinical practice of healthcare-associated infections with emergent highly drug-resistant (eHDR) pathogens, particularly carbapenem resistant enterobacteriaceae and glycopeptides-resistant enterococcus.
In 2022, a previous one-day point-prevalence multicenter study (NOSOREA2, NCT05547646) showed that most prevalent pathogens causing healthcare-associated infections were carbapenem resistant enterobacteriaceae. In 2017, (NOSOREA1, LA TUNISIE MEDICALE - 2018 ; Vol 96 (10/11)), most prevalent pathogens were non-fermenting pathogens. Faced with this major epidemiological change within Tunisian ICUs, we decided to launch a 3rd survey under the aegis of the 'Association tunisienne de réanimation'. We aimed to investigate the epidemiology, risk factors and impact on clinical practice of healthcare-associated infections with emergent highly drug-resistant (eHDR) pathogens, particularly carbapenem resistant enterobacteriaceae and glycopeptides-resistant enterococcus. So we conducted a multicenter prospective collection that will take place over 2 months.
Study Type
OBSERVATIONAL
Enrollment
500
Healthcare associated infections due to emergent highly resistant bacteria, sites, risk factors, treatment and outcome
Abderrahmen Mami
Ariana, Tunis Governorate, Tunisia
RECRUITINGHighly resistant bacterial healthcare associated infections
Incidence of eHRB healthcare associated infections in ICU
Time frame: 2 months
Epidemiological features of Highly resistant bacterial healthcare associated infections healthcare associated infections in ICU
Causative micro-organisms, sites and risk factors of eHRB healthcare associated infections in ICU
Time frame: 2 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.